Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia

Keyphrases

• Tolerability 100%
• Voriconazole 100%
• Renal Insufficiency 100%
• Candidemia 100%
• Fluconazole 70%
• Amphotericin B 70%
• Sulfobutylether-β-cyclodextrin 30%
• Treatment Outcome 20%
• Creatinine Clearance 20%
• Amphotericin B Deoxycholate 20%
• Treatment Survival 10%
• Exposure Time 10%
• Serum Creatinine 10%
• All-cause Mortality 10%
• Treatment Duration 10%
• Renal Impairment 10%
• Renal Toxicity 10%
• Short Course 10%
• Creatinine 10%
• Renal Function Improvement 10%
• Acutely Ill Patients 10%
• Treatment Safety 10%
• Treatment Tolerability 10%
• Renal Adverse Events 10%
• Intravenous Formulation 10%
• Return-to-baseline 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Tolerability 100%
• Kidney Failure 100%
• Voriconazole 100%
• Candidemia 100%
• Amphotericin B 70%
• Fluconazole 70%
• Creatinine 40%
• Beta Cyclodextrin 30%
• Amphotericin B Deoxycholate 20%
• Adverse Event 10%
• All Cause Mortality 10%
• Nephrotoxicity 10%
• Severe Renal Impairment 10%
• Moderate Renal Impairment 10%

INIS

• patients 100%
• safety 100%
• kidneys 100%
• comparative evaluations 36%
• creatinine 36%
• oligosaccharides 27%
• clearance 18%
• data 9%
• mortality 9%
• toxicity 9%